- Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis
-
Kamat N, Vuyyuru SK, Kedia S, Sahu P, Kante B, Kumar P, Ranjan MK, Singh MK, Kumar S, Sachdev V, Makharia G, Ahuja V
- KMID: 2529573
- Intest Res.
- 2022 Apr;20(2):269-273.
- doi: 10.5217/ir.2021.00064
-
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and tolerability of hyperbaric oxygen therapy in small bowel stricturing Crohn’s disease: a pilot study
-
Kante B, Sahu P, Kedia S, Vuyyuru SK, Soni K, Singhal M, Sharma R, Makharia G, Ahuja V
- KMID: 2529569
- Intest Res.
- 2022 Apr;20(2):231-239.
- doi: 10.5217/ir.2021.00056
Background/Aims: Existing therapeutic options for complicated Crohn’s disease (CD) like biologics and surgery are limited by inadequate long-term efficacy, cost, and adverse effects. Tissue hypoxia is important in CD pathogenesis... -
- CITED
-
- Close
- SHARE
-
- Close
- Addition of computed tomography chest increases the diagnosis rate in patients with suspected intestinal tuberculosis
-
Kedia S, Sharma R, Vuyyuru SK, Madhu D, Sahu P, Kante B, Das P, Goyal A, Madan K, Makharia G, Ahuja V
- KMID: 2529564
- Intest Res.
- 2022 Apr;20(2):184-191.
- doi: 10.5217/ir.2020.00104
Background/Aims: Intestinal tuberculosis (ITB) is difficult to diagnose due to poor sensitivity of definitive diagnostic tests. ITB may be associated with concomitant pulmonary tuberculosis (PTB) which may remain undetected on... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
-
Sharma S, Gupta A, Kedia S, Agarwal S, Singh N, Goyal S, Jain S, Gupta V, Sahu P, Vuyyuru SK, Kante B, Sharma R, Panwar R, Sahni P, Makharia G, Ahuja V
- KMID: 2518685
- Intest Res.
- 2021 Jul;19(3):291-300.
- doi: 10.5217/ir.2019.09172
Background/Aims: Exclusive enteral nutrition (EEN), an established modality for pediatric Crohn’s disease (CD) is seldomly utilized in adults. The present study reports the outcome of EEN in adult CD patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study
-
Mahajan R, Singh A, Kedia S, Kaur K, Midha V, Sahu P, Mehta V, Singh D, Bansal N, Dharni K, Kaushal S, Ahuja V, Sood A
- KMID: 2525073
- Intest Res.
- 2022 Jan;20(1):64-71.
- doi: 10.5217/ir.2020.00100
Background/Aims: Infliximab (IFX) has been used to induce and maintain remission in patients with severe steroid-refractory ulcerative colitis (UC). Long-term use of biologics in developing countries is limited by high... -
- CITED
-
- Close
- SHARE
-
- Close
- High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative colitis
-
Jain S, Namdeo D, Sahu P, Kedia S, Sahni P, Das P, Sharma R, Gupta V, Makharia G, Dar L, Travis SP, Ahuja V
- KMID: 2521607
- Intest Res.
- 2021 Oct;19(4):438-447.
- doi: 10.5217/ir.2020.00055
Background/Aims: Predictors of short-term outcome of intravenous (IV) steroid therapy in acute severe ulcerative colitis (ASUC) have been well described, but the impact of cytomegalovirus (CMV) infection as a predictor... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring
-
Kumar P, Vuyyuru SK, Das P, Kante B, Ranjan MK, Thomas DM, Mundhra S, Sahu P, Venigalla PM, Jain S, Goyal S, Golla R, Virmani S, Singh MK, Sachdeva K, Sharma R, Dash NR, Makharia G, Kedia S, Ahuja V
- KMID: 2547196
- Intest Res.
- 2023 Oct;21(4):460-470.
- doi: 10.5217/ir.2022.00128
Background/Aims: Evidence on predictors of primary nonresponse (PNR), and secondary loss of response (SLR) to anti-tumor necrosis factor (anti-TNF) agents in inflammatory bowel disease is scarce from Asia. We evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
